entertainment -WSS

entertainment

author：comprehensive 2025-09-02 08:19:19 - browse：3

Adderall XR capsules are displayed on Feb. 24, 2023. Drug shortages are growing in the United States, and experts see no clear path to resolving them. – health care policy coverage from STAT — Medicare has a new proposal to pay hospitals more to stockpile essential drugs, an effort to avoid shortages of chemotherapies and other drugs. Jenny Kane/AP

WASHINGTON — Medicare has a new proposal to pay hospitals more to stockpile essential drugs — an idea that comes as doctors report running low on critical chemotherapies and other drugs. But experts caution the policy could cause the very shortages that government officials are trying to avoid.

For years most of the solutions for addressing drug shortages have involved giving the Food and Drug Administration more power. During the Covid-19 pandemic, Congress empowered the FDA to make drug companies create backup plans for manufacturing facility interruptions, and to collect information from drug makers on where they source ingredients. The FDA also has the authority to prioritize reviews of applications for drugs in short supply and to prioritize inspections of manufacturing facilities that plan to ramp up production.

But Medicare has its own new idea: paying hospitals to create a “buffer stock” of 86 medicines that HHS deems critical. Medicare would not pay hospitals for the drugs. Rather, it would pay hospitals for the cost of managing a three-month inventory of the drugs. It published the proposal in a rule last week; it’s seeking comment now before it will weigh whether to finalize the policy.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Liquid biopsy for lung cancer is launched by Delfi

WSS

There's an unseen cost to disruptive road

CVS is on a mission to consolidate health care. Will it work?

Inaction leaves children at risk from dangerous chemotherapy drug

Dog Aging Project founders on what lies ahead after losing funding

Why Charlie Gard's case is so disturbing to Americans

A Q&A with the global head of Boehringer Ingelheim's innovation unit

leisure time

entertainment

hotspot

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Update the Apgar Score to remove skin color

How one medical school became remarkably diverse

Why Charlie Gard's case is so disturbing to Americans

Novavax promises a turnaround & Lilly roils the obesity market

High breast density mammograms need follow

Guidelines to prevent youth baseball injuries need more muscle

Printout prescription drug information shouldn’t go digital

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Sana to lay off nearly a third of staff, de

explore

Liquid biopsy for lung cancer is launched by Delfi

Inaction leaves children at risk from dangerous chemotherapy drug

3 questions for the future of Biden's cancer moonshot

Why age limits for politicians are a terrible idea

Why Charlie Gard's case is so disturbing to Americans

Was Amgen transparent enough on FDA's concern on cancer drug?

knowledge

leisure time

focus

leisure time